Report Detail
Global Biopharmaceutical Development Support Service Market Growth (Status and Outlook) 2023-2029
- RnM4502232 |
- 17 January, 2023 |
- Global |
- 104 Pages |
- LPI(LP Information) |
- Service & Software
The global Biopharmaceutical Development Support Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biopharmaceutical Development Support Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biopharmaceutical Development Support Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biopharmaceutical Development Support Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biopharmaceutical Development Support Service players cover Boston Analytical, Catalent lnc., Charles River Laboratories International lnc., Eurofins Scientific, Intertek Group, Merck KGaA, SGS SA, Solvias AG and STERIS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Biopharmaceutical Development Support Service Industry Forecast” looks at past sales and reviews total world Biopharmaceutical Development Support Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical Development Support Service sales for 2023 through 2029. With Biopharmaceutical Development Support Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical Development Support Service industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical Development Support Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biopharmaceutical Development Support Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical Development Support Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical Development Support Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical Development Support Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Development Support Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Test Suite
Testing Services
Testing Software
Other
Segmentation by application
Laboratory
Research Institutions
Pharmaceutical Center
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Analytical
Catalent lnc.
Charles River Laboratories International lnc.
Eurofins Scientific
Intertek Group
Merck KGaA
SGS SA
Solvias AG
STERIS
West Pharmaceutical Services Inc.
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Biopharmaceutical Development Support Service Market Size 2018-2029
- 2.1.2 Biopharmaceutical Development Support Service Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Biopharmaceutical Development Support Service Segment by Type
- 2.2.1 Test Suite
- 2.2.2 Testing Services
- 2.2.3 Testing Software
- 2.2.4 Other
- 2.3 Biopharmaceutical Development Support Service Market Size by Type
- 2.3.1 Biopharmaceutical Development Support Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Biopharmaceutical Development Support Service Market Size Market Share by Type (2018-2023)
- 2.4 Biopharmaceutical Development Support Service Segment by Application
- 2.4.1 Laboratory
- 2.4.2 Research Institutions
- 2.4.3 Pharmaceutical Center
- 2.4.4 Other
- 2.5 Biopharmaceutical Development Support Service Market Size by Application
- 2.5.1 Biopharmaceutical Development Support Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Biopharmaceutical Development Support Service Market Size Market Share by Application (2018-2023)
3 Biopharmaceutical Development Support Service Market Size by Player
- 3.1 Biopharmaceutical Development Support Service Market Size Market Share by Players
- 3.1.1 Global Biopharmaceutical Development Support Service Revenue by Players (2018-2023)
- 3.1.2 Global Biopharmaceutical Development Support Service Revenue Market Share by Players (2018-2023)
- 3.2 Global Biopharmaceutical Development Support Service Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Biopharmaceutical Development Support Service by Regions
- 4.1 Biopharmaceutical Development Support Service Market Size by Regions (2018-2023)
- 4.2 Americas Biopharmaceutical Development Support Service Market Size Growth (2018-2023)
- 4.3 APAC Biopharmaceutical Development Support Service Market Size Growth (2018-2023)
- 4.4 Europe Biopharmaceutical Development Support Service Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Biopharmaceutical Development Support Service Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Biopharmaceutical Development Support Service Market Size by Country (2018-2023)
- 5.2 Americas Biopharmaceutical Development Support Service Market Size by Type (2018-2023)
- 5.3 Americas Biopharmaceutical Development Support Service Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Biopharmaceutical Development Support Service Market Size by Region (2018-2023)
- 6.2 APAC Biopharmaceutical Development Support Service Market Size by Type (2018-2023)
- 6.3 APAC Biopharmaceutical Development Support Service Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Biopharmaceutical Development Support Service by Country (2018-2023)
- 7.2 Europe Biopharmaceutical Development Support Service Market Size by Type (2018-2023)
- 7.3 Europe Biopharmaceutical Development Support Service Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Biopharmaceutical Development Support Service by Region (2018-2023)
- 8.2 Middle East & Africa Biopharmaceutical Development Support Service Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Biopharmaceutical Development Support Service Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Biopharmaceutical Development Support Service Market Forecast
- 10.1 Global Biopharmaceutical Development Support Service Forecast by Regions (2024-2029)
- 10.1.1 Global Biopharmaceutical Development Support Service Forecast by Regions (2024-2029)
- 10.1.2 Americas Biopharmaceutical Development Support Service Forecast
- 10.1.3 APAC Biopharmaceutical Development Support Service Forecast
- 10.1.4 Europe Biopharmaceutical Development Support Service Forecast
- 10.1.5 Middle East & Africa Biopharmaceutical Development Support Service Forecast
- 10.2 Americas Biopharmaceutical Development Support Service Forecast by Country (2024-2029)
- 10.2.1 United States Biopharmaceutical Development Support Service Market Forecast
- 10.2.2 Canada Biopharmaceutical Development Support Service Market Forecast
- 10.2.3 Mexico Biopharmaceutical Development Support Service Market Forecast
- 10.2.4 Brazil Biopharmaceutical Development Support Service Market Forecast
- 10.3 APAC Biopharmaceutical Development Support Service Forecast by Region (2024-2029)
- 10.3.1 China Biopharmaceutical Development Support Service Market Forecast
- 10.3.2 Japan Biopharmaceutical Development Support Service Market Forecast
- 10.3.3 Korea Biopharmaceutical Development Support Service Market Forecast
- 10.3.4 Southeast Asia Biopharmaceutical Development Support Service Market Forecast
- 10.3.5 India Biopharmaceutical Development Support Service Market Forecast
- 10.3.6 Australia Biopharmaceutical Development Support Service Market Forecast
- 10.4 Europe Biopharmaceutical Development Support Service Forecast by Country (2024-2029)
- 10.4.1 Germany Biopharmaceutical Development Support Service Market Forecast
- 10.4.2 France Biopharmaceutical Development Support Service Market Forecast
- 10.4.3 UK Biopharmaceutical Development Support Service Market Forecast
- 10.4.4 Italy Biopharmaceutical Development Support Service Market Forecast
- 10.4.5 Russia Biopharmaceutical Development Support Service Market Forecast
- 10.5 Middle East & Africa Biopharmaceutical Development Support Service Forecast by Region (2024-2029)
- 10.5.1 Egypt Biopharmaceutical Development Support Service Market Forecast
- 10.5.2 South Africa Biopharmaceutical Development Support Service Market Forecast
- 10.5.3 Israel Biopharmaceutical Development Support Service Market Forecast
- 10.5.4 Turkey Biopharmaceutical Development Support Service Market Forecast
- 10.5.5 GCC Countries Biopharmaceutical Development Support Service Market Forecast
- 10.6 Global Biopharmaceutical Development Support Service Forecast by Type (2024-2029)
- 10.7 Global Biopharmaceutical Development Support Service Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 Boston Analytical
- 11.1.1 Boston Analytical Company Information
- 11.1.2 Boston Analytical Biopharmaceutical Development Support Service Product Offered
- 11.1.3 Boston Analytical Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Boston Analytical Main Business Overview
- 11.1.5 Boston Analytical Latest Developments
- 11.2 Catalent lnc.
- 11.2.1 Catalent lnc. Company Information
- 11.2.2 Catalent lnc. Biopharmaceutical Development Support Service Product Offered
- 11.2.3 Catalent lnc. Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Catalent lnc. Main Business Overview
- 11.2.5 Catalent lnc. Latest Developments
- 11.3 Charles River Laboratories International lnc.
- 11.3.1 Charles River Laboratories International lnc. Company Information
- 11.3.2 Charles River Laboratories International lnc. Biopharmaceutical Development Support Service Product Offered
- 11.3.3 Charles River Laboratories International lnc. Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Charles River Laboratories International lnc. Main Business Overview
- 11.3.5 Charles River Laboratories International lnc. Latest Developments
- 11.4 Eurofins Scientific
- 11.4.1 Eurofins Scientific Company Information
- 11.4.2 Eurofins Scientific Biopharmaceutical Development Support Service Product Offered
- 11.4.3 Eurofins Scientific Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Eurofins Scientific Main Business Overview
- 11.4.5 Eurofins Scientific Latest Developments
- 11.5 Intertek Group
- 11.5.1 Intertek Group Company Information
- 11.5.2 Intertek Group Biopharmaceutical Development Support Service Product Offered
- 11.5.3 Intertek Group Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Intertek Group Main Business Overview
- 11.5.5 Intertek Group Latest Developments
- 11.6 Merck KGaA
- 11.6.1 Merck KGaA Company Information
- 11.6.2 Merck KGaA Biopharmaceutical Development Support Service Product Offered
- 11.6.3 Merck KGaA Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Merck KGaA Main Business Overview
- 11.6.5 Merck KGaA Latest Developments
- 11.7 SGS SA
- 11.7.1 SGS SA Company Information
- 11.7.2 SGS SA Biopharmaceutical Development Support Service Product Offered
- 11.7.3 SGS SA Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 SGS SA Main Business Overview
- 11.7.5 SGS SA Latest Developments
- 11.8 Solvias AG
- 11.8.1 Solvias AG Company Information
- 11.8.2 Solvias AG Biopharmaceutical Development Support Service Product Offered
- 11.8.3 Solvias AG Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Solvias AG Main Business Overview
- 11.8.5 Solvias AG Latest Developments
- 11.9 STERIS
- 11.9.1 STERIS Company Information
- 11.9.2 STERIS Biopharmaceutical Development Support Service Product Offered
- 11.9.3 STERIS Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 STERIS Main Business Overview
- 11.9.5 STERIS Latest Developments
- 11.10 West Pharmaceutical Services Inc.
- 11.10.1 West Pharmaceutical Services Inc. Company Information
- 11.10.2 West Pharmaceutical Services Inc. Biopharmaceutical Development Support Service Product Offered
- 11.10.3 West Pharmaceutical Services Inc. Biopharmaceutical Development Support Service Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 West Pharmaceutical Services Inc. Main Business Overview
- 11.10.5 West Pharmaceutical Services Inc. Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Biopharmaceutical Development Support Service. Industry analysis & Market Report on Biopharmaceutical Development Support Service is a syndicated market report, published as Global Biopharmaceutical Development Support Service Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Biopharmaceutical Development Support Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
